Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Harvard Apparatus Regenerative Technology, Inc.
| Metric | Harvard Apparatus Regenerative Technology, Inc. HRGNHealthcare |
|---|---|
| Quality Score | 50 / 100 |
| Revenue (latest) | $704,000 |
| Net income (latest) | −$7M |
| Operating margin | −982.2% |
| Net margin | −975.7% |
| Return on equity | −649.9% |
| Return on assets | −256.6% |
| Return on capital (ROCE) | −605.0% |
| Debt / equity | 1.53× |
| Revenue growth (YoY) | 63.7% |
| Altman Z″ (distress) | -145.71 |
| Accruals / assets | −113.6% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.